Interestingly, high CLEC9A expression in the TME associates with favorable prognosis in human cancer (Böttcher et al., 2018) but whether DNGR-1 plays a role in anti-tumor immunity and if it can be subverted for immune escape is not known. Here, CLEC9A is linked to cancer.